These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 26923077)

  • 41. A brief retrospective report on the feasibility of epidermal growth factor receptor and KRAS mutation analysis in transesophageal ultrasound- and endobronchial ultrasound-guided fine needle cytological aspirates.
    Schuurbiers OC; Looijen-Salamon MG; Ligtenberg MJ; van der Heijden HF
    J Thorac Oncol; 2010 Oct; 5(10):1664-7. PubMed ID: 20871266
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endobronchial ultrasound doppler image features correlate with mRNA expression of HIF1-α and VEGF-C in patients with non-small-cell lung cancer.
    Nakajima T; Anayama T; Koike T; Shingyoji M; Castle L; Kimura H; Yoshino I; Yasufuku K
    J Thorac Oncol; 2012 Nov; 7(11):1661-7. PubMed ID: 23059773
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thymidylate synthase, dihydropyrimidine dehydrogenase, thymidine phosphorylase, orotate phosphoribosyltransferase mRNA expression in lung cancer metastatic lymph node samples obtained by endobronchial ultrasound-guided transbronchial needle aspiration: a pilot study.
    Nakajima T; Yasufuku K; Suzuki M; Hiroshima K; Nakatani Y; Fujisawa T; Yoshino I
    Clin Lung Cancer; 2011 Sep; 12(5):293-7. PubMed ID: 21791367
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MET gene copy number in non-small cell lung cancer: molecular analysis in a targeted tyrosine kinase inhibitor naïve cohort.
    Beau-Faller M; Ruppert AM; Voegeli AC; Neuville A; Meyer N; Guerin E; Legrain M; Mennecier B; Wihlm JM; Massard G; Quoix E; Oudet P; Gaub MP
    J Thorac Oncol; 2008 Apr; 3(4):331-9. PubMed ID: 18379349
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Down-regulation of RBSP3/CTDSPL, NPRL2/G21, RASSF1A, ITGA9, HYAL1 and HYAL2 genes in non-small cell lung cancer].
    Anedchenko EA; Dmitriev AA; Krasnov GS; Kondrat'eva TT; Kopantsev EP; Vinogradova TV; Zinov'eva MV; Zborovskaia IB; Polotskiĭ BE; Sakharova OV; Kashuba VI; Zabarovskiĭ ER; Senchenko VN
    Mol Biol (Mosk); 2008; 42(6):965-76. PubMed ID: 19140316
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer.
    Takizawa H; Kondo K; Fujino H; Kenzaki K; Miyoshi T; Sakiyama S; Tangoku A
    Br J Cancer; 2006 Jul; 95(1):75-9. PubMed ID: 16755294
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rapid diagnosis of lymph node metastasis in lung cancer with loop-mediated isothermal amplification assay using carcinoembryonic antigen-mRNA.
    Maeda J; Inoue M; Nakabayashi K; Otomo Y; Shintani Y; Ohta M; Okumura M; Matsuura N
    Lung Cancer; 2009 Sep; 65(3):324-7. PubMed ID: 19144442
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Frequent down-regulation of pim-1 mRNA expression in non-small cell lung cancer is associated with lymph node metastases.
    Warnecke-Eberz U; Bollschweiler E; Drebber U; Pohl A; Baldus SE; Hoelscher AH; Metzger R
    Oncol Rep; 2008 Sep; 20(3):619-24. PubMed ID: 18695914
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association between plasma hepatocyte growth factor and gefitinib resistance in patients with advanced non-small cell lung cancer.
    Han JY; Kim JY; Lee SH; Yoo NJ; Choi BG
    Lung Cancer; 2011 Nov; 74(2):293-9. PubMed ID: 21440951
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterisation and predictive value of epidermal growth factor receptor status using quantitative real-time PCR combined with immunohistochemistry on non-small cell lung cancer specimens.
    Hilbe W; Dlaska M; Dirnhofer S; Duba HC; Eisterer W; Oberwasserlechner F; Mildner A; Schmid T; Ammann K; Thaler J; Wöll E
    Int J Oncol; 2003 Oct; 23(4):893-9. PubMed ID: 12963967
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic value of acquired resistance-related molecules in Japanese patients with NSCLC treated with an EGFR-TKI.
    Uramoto H; Yamada T; Yano S; Kondo N; Hasegawa S; Tanaka F
    Anticancer Res; 2012 Sep; 32(9):3785-90. PubMed ID: 22993320
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Apelin expression in human non-small cell lung cancer: role in angiogenesis and prognosis.
    Berta J; Kenessey I; Dobos J; Tovari J; Klepetko W; Jan Ankersmit H; Hegedus B; Renyi-Vamos F; Varga J; Lorincz Z; Paku S; Ostoros G; Rozsas A; Timar J; Dome B
    J Thorac Oncol; 2010 Aug; 5(8):1120-9. PubMed ID: 20581707
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The expression of three genes in primary non-small cell lung cancer is associated with metastatic spread to the brain.
    Grinberg-Rashi H; Ofek E; Perelman M; Skarda J; Yaron P; Hajdúch M; Jacob-Hirsch J; Amariglio N; Krupsky M; Simansky DA; Ram Z; Pfeffer R; Galernter I; Steinberg DM; Ben-Dov I; Rechavi G; Izraeli S
    Clin Cancer Res; 2009 Mar; 15(5):1755-61. PubMed ID: 19190132
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer Is correlated with survival.
    Brabender J; Danenberg KD; Metzger R; Schneider PM; Park J; Salonga D; Hölscher AH; Danenberg PV
    Clin Cancer Res; 2001 Jul; 7(7):1850-5. PubMed ID: 11448895
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A phase II study of erlotinib monotherapy in pre-treated non-small cell lung cancer without EGFR gene mutation who have never/light smoking history: re-evaluation of EGFR gene status (NEJ006/TCOG0903).
    Matsumoto Y; Maemondo M; Ishii Y; Okudera K; Demura Y; Takamura K; Kobayashi K; Morikawa N; Gemma A; Ishimoto O; Usui K; Harada M; Miura S; Fujita Y; Sato I; Saijo Y;
    Lung Cancer; 2014 Nov; 86(2):195-200. PubMed ID: 25249428
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epidermal growth factor receptor mRNA in peripheral blood of patients with pancreatic, lung, and colon carcinomas detected by RT-PCR.
    Clarke LE; Leitzel K; Smith J; Ali SM; Lipton A
    Int J Oncol; 2003 Feb; 22(2):425-30. PubMed ID: 12527944
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Expression of special AT-rich sequence-binding protein mRNA and its clinicopathological significance in non-small cell lung cancer].
    Zhou LY; Liu F; Tong J; Chen QQ; Zhang FW
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):534-7. PubMed ID: 19304547
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathobiological implications of MUC4 in non-small-cell lung cancer.
    Majhi PD; Lakshmanan I; Ponnusamy MP; Jain M; Das S; Kaur S; Shimizu ST; West WW; Johansson SL; Smith LM; Yu F; Rolle CE; Sharma P; Carey GB; Batra SK; Ganti AK
    J Thorac Oncol; 2013 Apr; 8(4):398-407. PubMed ID: 23370366
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MET and phosphorylated MET as potential biomarkers in lung cancer.
    Tretiakova M; Salama AK; Karrison T; Ferguson MK; Husain AN; Vokes EE; Salgia R
    J Environ Pathol Toxicol Oncol; 2011; 30(4):341-54. PubMed ID: 22181983
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The clinical significance of hepatocyte growth factor for non-small cell lung cancer.
    Siegfried JM; Weissfeld LA; Luketich JD; Weyant RJ; Gubish CT; Landreneau RJ
    Ann Thorac Surg; 1998 Dec; 66(6):1915-8. PubMed ID: 9930468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.